Aaron Ondrey insider trades

Open-market stock purchases and sales by Aaron Ondrey, Chief Financial Officer at Rocket Pharmaceuticals, Inc, from SEC Form 4 filings since Sep 8, 2023.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • RCKT Rocket Pharmaceuticals, Inc: 2 sales, last Jul 3, 2025
  • MRTX Mirati Therapeutics, Inc: other filings, last Jan 23, 2024

Get free alerts when Aaron Ondrey files a new trade →